NO20042379L - Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider - Google Patents

Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider

Info

Publication number
NO20042379L
NO20042379L NO20042379A NO20042379A NO20042379L NO 20042379 L NO20042379 L NO 20042379L NO 20042379 A NO20042379 A NO 20042379A NO 20042379 A NO20042379 A NO 20042379A NO 20042379 L NO20042379 L NO 20042379L
Authority
NO
Norway
Prior art keywords
polypeptides
pai
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20042379A
Other languages
English (en)
Norwegian (no)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20042379L publication Critical patent/NO20042379L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20042379A 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider NO20042379L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101671 2001-11-09
PCT/DK2002/000735 WO2003039580A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides

Publications (1)

Publication Number Publication Date
NO20042379L true NO20042379L (no) 2004-06-08

Family

ID=8160829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042379A NO20042379L (no) 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider

Country Status (15)

Country Link
EP (1) EP1446146A1 (ja)
JP (1) JP2005510514A (ja)
KR (1) KR20050043733A (ja)
CN (1) CN1596122A (ja)
AU (1) AU2002340778B2 (ja)
BR (1) BR0213952A (ja)
CA (1) CA2464614A1 (ja)
CZ (1) CZ2004535A3 (ja)
HU (1) HUP0401959A3 (ja)
IL (1) IL161523A0 (ja)
NO (1) NO20042379L (ja)
PL (1) PL370118A1 (ja)
RU (1) RU2304980C2 (ja)
WO (1) WO2003039580A1 (ja)
ZA (1) ZA200403270B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009045412A2 (en) * 2007-10-01 2009-04-09 American Diagnostica, Inc. Methods of treatment using modified plasminogen activator inhibitor type-1 molecules
WO2020103930A1 (zh) * 2018-11-22 2020-05-28 上海科技大学 噻唑并环类化合物、其制备方法、中间体和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
DE60143292D1 (de) * 2000-05-03 2010-12-02 Novo Nordisk Healthcare Ag Varianten des menschlichen Koagulationsfaktors VII

Also Published As

Publication number Publication date
KR20050043733A (ko) 2005-05-11
JP2005510514A (ja) 2005-04-21
RU2004117535A (ru) 2005-04-10
HUP0401959A2 (hu) 2004-12-28
IL161523A0 (en) 2004-09-27
AU2002340778B2 (en) 2007-08-02
WO2003039580A1 (en) 2003-05-15
CZ2004535A3 (cs) 2005-01-12
HUP0401959A3 (en) 2009-03-30
CN1596122A (zh) 2005-03-16
CA2464614A1 (en) 2003-05-15
BR0213952A (pt) 2004-08-31
ZA200403270B (en) 2004-11-08
RU2304980C2 (ru) 2007-08-27
PL370118A1 (en) 2005-05-16
EP1446146A1 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033143L (no) Farmasoytisk preparat
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20033556D0 (no) Farmasöytiske preparater
FI20011478A0 (fi) Farmaseuttinen koostumus
IL159015A0 (en) Polypeptides, their preparation and use
HUP0500989A2 (en) Animicrobial polypeptides and their uses
DK200300344U1 (da) Amlodipinmaleat og farmaceutisk præparat indeholdende amlodipinmaleat
NO20040235L (no) Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider
GB0108470D0 (en) Pharmaceutical compositions and their use
NO20025805L (no) Farmasöytisk preparat
IL158397A0 (en) Polypeptides, their preparation and their use
EP1462455A4 (en) NOVEL PEPTIDES AND THEIR USES AS MEDICAMENTS
IL159872A0 (en) Gmg-2 polypeptides and their use
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20042380L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider
EP1379228A4 (en) (Z) -STYRYLBENZYLSULPONES AND THEIR PHARMACEUTICAL APPLICATIONS
NO20042379L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20015534D0 (no) Farmasöytisk blandeapparat
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EP1437363A4 (en) MEDICINAL TRANSPORT AND USE THEREOF
AU2002340777A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
AU2002340784A1 (en) Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides